Cargando…

Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems

BACKGROUND: The understanding of the impact of COVID‐19 in patients with cancer is evolving, with need for rapid analysis. AIMS: This study aims to compare the clinical and demographic characteristics of patients with cancer (with and without COVID‐19) and characterize the clinical outcomes of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Clara, Izano, Monika A., Thompson, Michael A., Gadgeel, Shirish M., Weese, James L., Mikkelsen, Tom, Schrag, Andrew, Teka, Mahder, Walters, Sheetal, Wolf, Frank M., Hirsch, Jonathan, Rivera, Donna R., Kluetz, Paul G., Singh, Harpreet, Brown, Thomas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209944/
https://www.ncbi.nlm.nih.gov/pubmed/34014037
http://dx.doi.org/10.1002/cnr2.1388
_version_ 1783709217818935296
author Hwang, Clara
Izano, Monika A.
Thompson, Michael A.
Gadgeel, Shirish M.
Weese, James L.
Mikkelsen, Tom
Schrag, Andrew
Teka, Mahder
Walters, Sheetal
Wolf, Frank M.
Hirsch, Jonathan
Rivera, Donna R.
Kluetz, Paul G.
Singh, Harpreet
Brown, Thomas D.
author_facet Hwang, Clara
Izano, Monika A.
Thompson, Michael A.
Gadgeel, Shirish M.
Weese, James L.
Mikkelsen, Tom
Schrag, Andrew
Teka, Mahder
Walters, Sheetal
Wolf, Frank M.
Hirsch, Jonathan
Rivera, Donna R.
Kluetz, Paul G.
Singh, Harpreet
Brown, Thomas D.
author_sort Hwang, Clara
collection PubMed
description BACKGROUND: The understanding of the impact of COVID‐19 in patients with cancer is evolving, with need for rapid analysis. AIMS: This study aims to compare the clinical and demographic characteristics of patients with cancer (with and without COVID‐19) and characterize the clinical outcomes of patients with COVID‐19 and cancer. METHODS AND RESULTS: Real‐world data (RWD) from two health systems were used to identify 146 702 adults diagnosed with cancer between 2015 and 2020; 1267 COVID‐19 cases were identified between February 1 and July 30, 2020. Demographic, clinical, and socioeconomic characteristics were extracted. Incidence of all‐cause mortality, hospitalizations, and invasive respiratory support was assessed between February 1 and August 14, 2020. Among patients with cancer, patients with COVID‐19 were more likely to be Non‐Hispanic black (NHB), have active cancer, have comorbidities, and/or live in zip codes with median household income <$30 000. Patients with COVID‐19 living in lower‐income areas and NHB patients were at greatest risk for hospitalization from pneumonia, fluid and electrolyte disorders, cough, respiratory failure, and acute renal failure and were more likely to receive hydroxychloroquine. All‐cause mortality, hospital admission, and invasive respiratory support were more frequent among patients with cancer and COVID‐19. Male sex, increasing age, living in zip codes with median household income <$30 000, history of pulmonary circulation disorders, and recent treatment with immune checkpoint inhibitors or chemotherapy were associated with greater odds of all‐cause mortality in multivariable logistic regression models. CONCLUSION: RWD can be rapidly leveraged to understand urgent healthcare challenges. Patients with cancer are more vulnerable to COVID‐19 effects, especially in the setting of active cancer and comorbidities, with additional risk observed in NHB patients and those living in zip codes with median household income <$30 000.
format Online
Article
Text
id pubmed-8209944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82099442021-06-21 Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems Hwang, Clara Izano, Monika A. Thompson, Michael A. Gadgeel, Shirish M. Weese, James L. Mikkelsen, Tom Schrag, Andrew Teka, Mahder Walters, Sheetal Wolf, Frank M. Hirsch, Jonathan Rivera, Donna R. Kluetz, Paul G. Singh, Harpreet Brown, Thomas D. Cancer Rep (Hoboken) Original Articles BACKGROUND: The understanding of the impact of COVID‐19 in patients with cancer is evolving, with need for rapid analysis. AIMS: This study aims to compare the clinical and demographic characteristics of patients with cancer (with and without COVID‐19) and characterize the clinical outcomes of patients with COVID‐19 and cancer. METHODS AND RESULTS: Real‐world data (RWD) from two health systems were used to identify 146 702 adults diagnosed with cancer between 2015 and 2020; 1267 COVID‐19 cases were identified between February 1 and July 30, 2020. Demographic, clinical, and socioeconomic characteristics were extracted. Incidence of all‐cause mortality, hospitalizations, and invasive respiratory support was assessed between February 1 and August 14, 2020. Among patients with cancer, patients with COVID‐19 were more likely to be Non‐Hispanic black (NHB), have active cancer, have comorbidities, and/or live in zip codes with median household income <$30 000. Patients with COVID‐19 living in lower‐income areas and NHB patients were at greatest risk for hospitalization from pneumonia, fluid and electrolyte disorders, cough, respiratory failure, and acute renal failure and were more likely to receive hydroxychloroquine. All‐cause mortality, hospital admission, and invasive respiratory support were more frequent among patients with cancer and COVID‐19. Male sex, increasing age, living in zip codes with median household income <$30 000, history of pulmonary circulation disorders, and recent treatment with immune checkpoint inhibitors or chemotherapy were associated with greater odds of all‐cause mortality in multivariable logistic regression models. CONCLUSION: RWD can be rapidly leveraged to understand urgent healthcare challenges. Patients with cancer are more vulnerable to COVID‐19 effects, especially in the setting of active cancer and comorbidities, with additional risk observed in NHB patients and those living in zip codes with median household income <$30 000. John Wiley and Sons Inc. 2021-05-20 /pmc/articles/PMC8209944/ /pubmed/34014037 http://dx.doi.org/10.1002/cnr2.1388 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. This article has been contributed to by US Government employees and their work is in the public domain in the USA. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hwang, Clara
Izano, Monika A.
Thompson, Michael A.
Gadgeel, Shirish M.
Weese, James L.
Mikkelsen, Tom
Schrag, Andrew
Teka, Mahder
Walters, Sheetal
Wolf, Frank M.
Hirsch, Jonathan
Rivera, Donna R.
Kluetz, Paul G.
Singh, Harpreet
Brown, Thomas D.
Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
title Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
title_full Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
title_fullStr Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
title_full_unstemmed Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
title_short Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
title_sort rapid real‐world data analysis of patients with cancer, with and without covid‐19, across distinct health systems
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209944/
https://www.ncbi.nlm.nih.gov/pubmed/34014037
http://dx.doi.org/10.1002/cnr2.1388
work_keys_str_mv AT hwangclara rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT izanomonikaa rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT thompsonmichaela rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT gadgeelshirishm rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT weesejamesl rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT mikkelsentom rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT schragandrew rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT tekamahder rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT walterssheetal rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT wolffrankm rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT hirschjonathan rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT riveradonnar rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT kluetzpaulg rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT singhharpreet rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems
AT brownthomasd rapidrealworlddataanalysisofpatientswithcancerwithandwithoutcovid19acrossdistincthealthsystems